Categories: News

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BSX, SPLK, SWI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

NEW ORLEANS, Jan. 08, 2021 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

Boston Scientific Corporation (BSX)
Class Period: 4/24/2019 – 11/16/2020
Lead Plaintiff Motion Deadline: February 2, 2021
SECURITIES FRAUD
To learn more, visit https://www.ksfcounsel.com/cases/nyse-bsx/

Splunk Inc. (SPLK)
Class Period: 10/21/2020 – 12/2/2020
Lead Plaintiff Motion Deadline: February 2, 2021
SECURITIES FRAUD
To learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-splk/

SolarWinds Corporation (SWI)
Class Period: 2/24/2020 – 12/15/2020
Lead Plaintiff Motion Deadline: March 5, 2021
SECURITIES FRAUD
To learn more, visit https://www.ksfcounsel.com/cases/nyse-swi/

If you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

About
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

Staff

Recent Posts

Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Administration of CardiolRx™ led to a marked reduction in the primary efficacy endpoint of pericarditis…

52 mins ago

Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA

Toronto, Ontario--(Newsfile Corp. - June 13, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF)…

52 mins ago

Laerdal Medical selects IFS Cloud to drive growth and transition to new business models

IFS will provide an 'out-of-the-box solution' to support digital transformation and supply chain re-design for…

3 hours ago

New Scientific Article Published on Positive Clinical Results with Painless ACD440 Against Neuropathic Pain

STOCKHOLM, SWEDEN / ACCESSWIRE / June 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB…

3 hours ago

Momcozy Introduces the Mobile Flow™ Hands-free Breast Pump

DENVER, June 12, 2024 /PRNewswire/ -- Momcozy, a leading provider of maternity products and nursing…

9 hours ago